Skip to main content
CAMBIUM BIO LIMITED logo

CAMBIUM BIO LIMITED — Investor Relations & Filings

Ticker · CMB ISIN · AU0000327769 ASX Professional, scientific and technical activities
Open in API
Filings indexed 504 across all filing types
Latest filing 2015-10-07 AGM Information
Country AU Australia
Listing ASX CMB

About CAMBIUM BIO LIMITED

https://www.cambium.bio

Cambium Bio Limited is a clinical-stage regenerative medicine company focused on developing innovative cellular therapies to treat unmet medical needs in ophthalmology and inflammatory diseases. The company's primary focus is on its lead candidate, EluRegen, a first-in-class topical biologic designed for the treatment of corneal epithelial defects and dry eye disease. Utilizing its proprietary technology platforms, the company aims to harness the regenerative potential of biologics to provide effective treatments for chronic conditions. In addition to its ophthalmic pipeline, the company maintains assets in the field of mesenchymal stem cell therapies, including Progenza, which targets osteoarthritis and neuropathic pain. The company emphasizes a data-driven approach to clinical development, seeking to improve patient outcomes through advanced tissue engineering and cell-based solutions.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting / Proxy Form 14 pages 3.2MB
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting' and includes detailed information about the AGM scheduled for 9 November 2015. It contains the Notice of Meeting, resolutions to be voted on (including adoption of the Remuneration Report, re-election of a director, and approval of additional placement capacity), voting exclusion statements, instructions for proxies, and an explanatory statement to assist shareholders in understanding the resolutions. The document references the financial report and auditor's report to be laid before the meeting but does not contain the financial statements themselves. It is a formal notice and explanatory material for the AGM, not the actual Annual Report or financial statements. Therefore, this document fits the category of AGM Information (AGM-R).
2015-10-07 English
Appendix 3B - Restricted securities released from escrow 12 pages 487.3KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to securities issuance. It contains detailed information about the class of securities issued, number of securities, issue price, purpose of the issue, and other related details. This type of document is specifically used to announce capital raising or changes in capital structure, such as new share issues or options issuance. It is not a full financial report, earnings release, or management discussion, nor is it a regulatory filing or announcement of a report publication. Therefore, the correct classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a substantive announcement, not a brief notice or certification.
2015-09-21 English
Restricted Securities to be released from escrow 1
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Regeneus Ltd regarding the release of restricted securities from escrow, referencing ASX Listing Rule 3.10A. It does not contain financial statements or detailed financial data, nor does it announce a report publication. It is an update on capital structure related to share release from escrow, which fits best under Capital/Financing Update (CAP). The document length is very short (427 characters), confirming it is an announcement rather than a full report.
2015-09-03 English
Date of AGM 1 page 130.3KB
AGM Information Classification · 95% confidence The document is a short announcement from Regeneus Ltd regarding the date and location of its 2015 Annual General Meeting (AGM). It references the ASX Listing Rule 3.13.1, which relates to notifying the market of the AGM date. The document does not contain any financial data, detailed presentations, or voting results. It simply informs shareholders about the upcoming AGM and states that a formal notice will be sent later. Given the short length (536 characters) and the nature of the content, this is an announcement related to the AGM but not the AGM materials themselves. According to the classification rules, such announcements about the AGM date fall under AGM Information (AGM-R).
2015-09-01 English
FY15 Preliminary Final Report 50 pages 2.9MB
Annual Report Classification · 100% confidence The document contains detailed consolidated financial statements for the year ended 30 June 2015, including a Directors' Report, Auditor's Independence Declaration, Corporate Governance Statement, financial statements, notes, and an Independent Auditor's Report. It includes comprehensive financial data, operational review, and governance information typical of a full annual report. The presence of detailed financial tables, director information, and auditor's report confirms this is the full Annual Report for the fiscal year ending 30 June 2015. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2015
2015-08-30 English
FY15 Full-Year Results and Business Update Announcement 2 pages 207.8KB
Earnings Release Classification · 90% confidence The document is an ASX announcement reporting the company's full-year financial results and business update for the fiscal year 2015. It includes financial highlights such as revenues, net loss, cash flow, and capital raising details, as well as business progress and strategic focus. The document is about 4555 characters long, which is relatively short but contains substantive financial data and business commentary. It is not merely an announcement of a report being published but provides actual financial results and business updates. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights. It is not a full Annual Report (10-K) or Interim Report (IR) as it lacks comprehensive financial statements and detailed analysis, but it is more than a simple announcement or regulatory filing. Hence, the best classification is Earnings Release (ER). FY 2015
2015-08-30 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.